Question 1

How many shares of MNPR does WELLS FARGO & COMPANY/MN own?

Accepted Answer

As of 2026-Q2, WELLS FARGO & COMPANY/MN holds 3,958 shares of MNPR (MONOPAR THERAPEUTICS INC).

Question 2

What is WELLS FARGO & COMPANY/MN's MNPR position worth?

Accepted Answer

As of 2026-Q2, WELLS FARGO & COMPANY/MN's MNPR position is worth $366,471.

Question 3

Is WELLS FARGO & COMPANY/MN buying or selling MNPR?

Accepted Answer

In 2026-Q2, WELLS FARGO & COMPANY/MN increased their MNPR position (+129.1% change in shares).

Question 4

When did WELLS FARGO & COMPANY/MN first buy MNPR?

Accepted Answer

Based on available 13F filings, WELLS FARGO & COMPANY/MN first reported a position in MNPR in 2024-Q3. They have held the position across 8 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	3,958	+129.1%	$366,471	0.0%	$92.59	38
2026-Q1	Decreased	1,728	-66.3%	$94,678	0.0%	$51.88	0
2025-Q4	Increased	5,125	+120.8%	$334,664	0.0%	$65.07	38
2025-Q3	Increased	2,321	+0.9%	$189,556	0.0%	$75.90	16
2025-Q2	Increased	2,301	+820.4%	$82,330	0.0%	$33.60	24
2025-Q1	Unchanged	250	0.0%	$9,103	0.0%	$40.33	0
2024-Q4	Decreased	250	-50.0%	$5,500	0.0%	$23.85	0
2024-Q3	New	500	—	$3,370	0.0%	$6.77	21